...
首页> 外文期刊>Journal of Clinical Microbiology >Systemic Infection of an Immunocompromised Patient with Methylobacterium zatmanii
【24h】

Systemic Infection of an Immunocompromised Patient with Methylobacterium zatmanii

机译:扎曼氏甲基杆菌免疫功能低下患者的全身感染

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We describe the identification of Methylobacterium zatmanii as the causative agent of bacteremia and fever in an immunocompromised patient. The patient, a 60-year-old man, had a 5-month history of acute myeloid leukemia and had been on chemotherapy throughout this period. Seven days after the onset of neutropenia, the patient developed fever. The combination of ciprofloxacin, co-trimoxazole, imipenem, amikacin, and vancomycin led to a complete defervescence. On subculture from six positive blood cultures, the organism grew only on buffered charcoal yeast extract agar and not on standard agars. Identification by universal PCR and subsequent sequence analysis of the amplified 16S rRNA gene segment was achieved. This identification by molecular biology techniques was confirmed by conventional biochemical tests. To our knowledge, this is the first description of M. zatmaniiisolated from patient material.
机译:我们描述了 zatmanii甲烷杆菌的鉴定,它是免疫受损患者中菌血症和发烧的病原体。该患者是一名60岁的男性,有5个月的急性髓样白血病病史,并且在此期间一直接受化疗。中性粒细胞减少症发作后七天,患者发烧。环丙沙星,co-trimoxazole,亚胺培南,丁胺卡那霉素和万古霉素的组合导致完全去磁。在六个阳性血液培养物中进行继代培养时,该生物仅在缓冲的木炭酵母提取琼脂上生长,而在标准琼脂上不生长。通过通用PCR鉴定并随后对扩增的16S rRNA基因区段进行序列分析。通过分子生物学技术进行的这种鉴定已通过常规生化测试得到证实。据我们所知,这是 M的第一个描述。扎特曼氏菌从患者材料中分离出来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号